MMP9 and head and neck squamous cell carcinoma: More than 50 MMP inhibitors have been investigated in various cancers, but all have failed [39], and in a study consisting of 37 HNSCC patients treated with cisplatin and cetuximab, a high mRNA expression of MMP9 was associated with objective treatment response [40].